Changes in treatment satisfaction
| Sitagliptin | p Value* | Mitiglinide | p Value* | p Value† | |||
|---|---|---|---|---|---|---|---|
| Before | After | Before | After | ||||
| Q1 | 4.1±1.7 | 4.9±1.1 | 0.057 | 4.3±0.3 | 4.8±0.3 | 0.197 | 0.620 |
| Q2 | 3.1±1.4 | 2.6±1.7 | 0.264 | 2.6±0.3 | 2.9±0.4 | 0.412 | 0.170 |
| Q3 | 2.3±1.9 | 1.9±1.9 | 0.358 | 1.3±0.2 | 1.9±0.4 | 0.166 | 0.110 |
| Q4 | 3.7±1.7 | 5.2±0.9 | 0.000 | 3.0±0.4 | 5.0±0.3 | 0.000 | 0.268 |
| Q5 | 3.7±1.3 | 4.7±1.3 | 0.006 | 3.1±0.4 | 4.8±0.3 | 0.000 | 0.146 |
| Q6 | 4.1±1.3 | 4.6±1.0 | 0.043 | 4.6±0.2 | 4.5±0.3 | 0.887 | 0.154 |
| Q7 | 4.3±1.5 | 5.0±0.8 | 0.013 | 3.7±0.4 | 4.4±0.3 | 0.052 | 0.931 |
| Q8 | 4.1±1.6 | 5.1±1.0 | 0.002 | 3.7±0.4 | 4.8±0.3 | 0.008 | 1.000 |
| Sum | 24.2±6.7 | 29.6±4.5 | 0.000 | 22.3±1.6 | 28.4±1.3 | 0.001 | 0.759 |
Treatment satisfaction score: sum of items 1, 4, 5, 6, 7, and 8. Data are means±SD.
*p Value for the intragroup comparison (baseline vs 16 weeks).
†p Value for the intergroup comparison (change from baseline between groups).